We Shouldn’t Give Up on Biosimilars—And Here Are the Data to Prove it

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 10, 2019 at 10:52 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via An interesting spat about biosimilars has emerged between two prominent policy-oriented physicians.

    Dr. Peter Bach of Memorial Sloan Kettering argues that we should “throw in the towel” on biosimilars and begin regulating drug prices.

    On the other side, Dr. Scott Gottlieb, a former FDA commissioner, argues that we shouldn’t give up on biosimilars, but instead make structural and legislative changes that would increase competition.

    article source